Vas Narasimhan, Novartis CEO (Jason Alden/Bloomberg via Getty Images)
February 22, 2021 07:19 AM ESTUpdated February 25, 01:36 AM
People

Vas Narasimhan gets a bump in pay, but still falls well be­low some ri­vals

Jason Mast

Editor

Vas­ant Narasimhan has nev­er sat down with a re­porter and com­plained about his mul­ti-mil­lion dol­lar pay pack­age, al­though per­haps it wouldn’t be the worst idea …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times